Alcami Adds Additional Formulation Development Capabilities
Formulation Development Suite to Support Small and Large Molecule Programs
Morrisville, North...
Posts about
Analytical Development
Alcami Expands Biologics Footprint with Investment in Durham
$10 Million Investment Doubles Laboratory Footprint & Enhances Large Molecule and Cell & Gene...
Bioanalytical Testing Trends in 2022
An increasing number of clinical trial registrations, more R&D investment, growing demand for...
Alcami Announces the Acquisition of Masy BioServices
Acquisition to add 375,000 ft² of cGMP Biostorage and Pharma Support Services
Alcami to Provide Analytical Support Services for Novavax’ COVID-19 Vaccine Candidate
DURHAM, N.C. – November 16, 2021 – Alcami, a leading United States-based contract development and...
Outsourcing Trends in the Development of Biologics
The development of biologic drugs continues to increase at a rapid pace. Growing numbers of...
Fill-Finish Development Challenges & Solutions for CDMOs
Recently, contract development and manufacturing organizations (CDMOs) involved in the...
White Paper: Host Cell Impurities, Bioassays, Micro-Flow Imaging
As opposed to traditional drug production, the production of biological products (biologics)...
On-Demand Lab Open House
From standalone projects through full-service programs, our laboratories provide solutions to your...
White Paper: Leveraging Inductively Coupled Plasma Mass Spectrometry To Its Full Potential
Today’s technology has not only changed the way we receive information, but has continually adapted...
Full-Time Equivalent Programs: Outsourcing Analytical Testing
Alcami’s end-to-end analytical testing platform supports clients’ programs through every stage of a
Benefits of Establishing a Full-Time Equivalent (FTE) Program
A Full-Time Equivalent (FTE) agreement is a comprehensive analytical service that grants...
Alcami Helps Secure FDA Approval for MDGH
Durham, NC (USA) – October 25, 2018 – Alcami Corporation, a leading provider of fully-integrated...
ON-DEMAND WEBINAR: Extractables & Leachables
Requirements from regulatory agencies have become increasingly rigorous with regards to the...
The Role of FTE (FULL TIME EQUIVALENT) Programs
An FTE agreement is considered a comprehensive analytical service that allows pharmaceutical and...
Alcami’s Extended Workbench Supports Commercial Supply of Flexion Therapeutics’s ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
Durham, NC (USA) – June 13, 2018 – Alcami Corporation, a leading provider of fully-integrated...
Abuse-Deterrent Studies – An Interview with Angela Moore
As one of the key contributors to current abuse-deterrent studies being performed in the Alcami...